Entera Bio Ltd. (ENTX)
2.84
-0.17
(-5.65%)
USD |
NASDAQ |
Sep 09, 16:00
2.86
+0.02
(+0.70%)
After-Hours: 18:10
Entera Bio Price : 2.84 for Sept. 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 2.95 | 3.07 | 2.82 | 3.01 | 824637.0 |
| Sep 04, 2026 | 2.95 | 3.15 | 2.88 | 3.00 | 606922.0 |
| Sep 03, 2026 | 2.99 | 3.025 | 2.90 | 2.95 | 154038.0 |
| Sep 02, 2026 | 2.90 | 3.00 | 2.84 | 2.92 | 143497.0 |
| Sep 01, 2026 | 2.94 | 3.09 | 2.80 | 2.90 | 256682.0 |
| Aug 31, 2026 | 3.03 | 3.09 | 2.915 | 2.95 | 214454.0 |
| Aug 28, 2026 | 3.12 | 3.15 | 3.00 | 3.03 | 138183.0 |
| Aug 27, 2026 | 3.20 | 3.41 | 3.03 | 3.08 | 240676.0 |
| Aug 26, 2026 | 3.46 | 3.47 | 3.10 | 3.19 | 523310.0 |
| Aug 25, 2026 | 3.42 | 3.560 | 3.405 | 3.47 | 429970.0 |
| Aug 24, 2026 | 3.28 | 3.47 | 3.20 | 3.42 | 258132.0 |
| Aug 21, 2026 | 3.22 | 3.34 | 3.14 | 3.23 | 441300.0 |
| Aug 20, 2026 | 3.01 | 3.33 | 3.00 | 3.22 | 468468.0 |
| Aug 19, 2026 | 2.93 | 3.210 | 2.880 | 3.11 | 696062.0 |
| Aug 18, 2026 | 2.89 | 2.969 | 2.81 | 2.89 | 261718.0 |
| Aug 17, 2026 | 2.83 | 2.97 | 2.82 | 2.90 | 305878.0 |
| Aug 14, 2026 | 2.85 | 2.92 | 2.75 | 2.89 | 278331.0 |
| Aug 13, 2026 | 2.78 | 2.92 | 2.76 | 2.87 | 246482.0 |
| Aug 12, 2026 | 3.03 | 3.03 | 2.75 | 2.80 | 410048.0 |
| Aug 11, 2026 | 2.98 | 3.059 | 2.754 | 3.00 | 487986.0 |
| Aug 10, 2026 | 2.83 | 3.10 | 2.66 | 3.04 | 727310.0 |
| Aug 07, 2026 | 2.80 | 2.97 | 2.80 | 2.87 | 244946.0 |
| Aug 06, 2026 | 2.79 | 2.99 | 2.725 | 2.82 | 387933.0 |
| Aug 05, 2026 | 2.84 | 2.84 | 2.70 | 2.81 | 308519.0 |
| Aug 04, 2026 | 2.93 | 2.99 | 2.74 | 2.87 | 841548.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| BioLineRx Ltd. | 2.54 |
| XTL Biopharmaceuticals Ltd. | 2.52 |
| Kamada Ltd. | 8.21 |
| Can-Fite BioPharma Ltd. | 2.21 |
| Galmed Pharmaceuticals Ltd. | 4.58 |
Price Related Metrics
| PEG Ratio | -0.2188 |
| Price to Book Value | 19.27 |
| Earnings Yield | -12.38% |
| Market Cap | 139.98M |
| PEGY Ratio | -0.2188 |